444 third-party lab reports published 3 for the price of 2 on compound vials and capsules — put any 3 in your cart and the cheapest one is free, automatically. Solvents and lab supplies excluded. Ends Monday night. For research use only. 99.59% median purity across 251 lots Defense, VA, Federal and Public safety: your VerifyPass code adds 5% on top of 3 for the price of 2 · get verified 239 / 239 lots pass sterility

‹ Certificates Tesamorelin Lot 1777

Lab report (Certificate of Analysis, COA)

Tesamorelin · 11.99 mg

Batch 1777 · tested September 9, 2026 (10 days ago) · released September 18, 2026

All tests passed

Batch
#1777 14 of 15 tests
Mass
10 mg · tested 11.99 mg
Purity
99.08%
Issuing lab accreditation
Vanguard · ISO 17025:2017 / A2LA #6377.01.01

3 units tested for purity: 99.08 / 99.05 / 99.13% · spread 0.08 pt · net peptide content 11.88 / 12.01 / 12.09 mg

Conformity: Units agree — every reported unit passed on all 11 test rows · purity spread 0.08 pt within the house limit · content spread 1.8% within the house limit · QA approval corroborates: Vanguard Laboratory, Tori Johnson, Operations Manager, 2026-09-09

Vanguard · issuing lab

Reports for this lot

  1. Vanguard Laboratory this report · tested September 9, 2026 · 11 results · QA approvalVanguard · issuing labAll tests passed

Test by test

11 results on the report · 3 rows computed from the per-unit values · 1 ISO 17025:2017-accredited lab · each test used up to 5 vials from this lot (rows are not added together) · every row names the chapter or house rule it follows

IdentityPass
1 of 1 pass · 1 unit · USP <621> (procedural chapter)
PurityWithin limits
avg 99.09% · 3 units · USP <621> (procedural chapter)
Purity consistency between unitsWithin house limit
3 units: 99.08 / 99.05 / 99.13% · spread 0.08 pt · house limit · caution past 0.50 pt, outside past 1.00 pt · per-unit USP <621> results
Net peptide content (assay)Within limits
avg 11.99 mg · 3 units · USP <621> (procedural chapter)
Content consistency between unitsWithin house limit
3 units: 11.88 / 12.01 / 12.09 mg · spread 0.21 mg, 1.8% of the mean · house check · caution past 5%, outside past 10% · USP <905> is the compendial reference for between-unit uniformity (10 units; not claimable on 3)
Heavy metalsWithin limits
all non-detect · 2 units · dose-scaled limits derived from USP <232> (limits chapter)
Residual solventsWithin limits
all non-detect · 1 unit · USP <467> (procedural chapter)
Trifluoroacetic acidWithin limits
all non-detect · 1 unit · house limit · ion chromatography, the lab's method; no compendial chapter for the method run · limit <0.10% (the lab's)
EndotoxinsPass
3 of 3 pass · 3 units · USP <85> (procedural chapter) · limit <5.00 EU/mg (the lab's)
Container closurePass
3 of 3 pass · 3 units · USP <1207> (informational chapter (1000-series))
SolubilityPass
3 of 3 pass · 3 units · house check · no compendial chapter
SterilityPass
5 of 5 pass · 5 units · USP <71> (procedural chapter)
Other · Adulterant screenWithin limits
all non-detect · 1 unit · no chapter named in the record; a screen
ConformityUnits agree
every reported unit passed on all 11 test rows · purity spread 0.08 pt within the house limit · content spread 1.8% within the house limit · QA approval corroborates: Vanguard Laboratory, Tori Johnson, Operations Manager, 2026-09-09 · house check · agreement across all tests, unit to unit; QA approval corroborates

A chapter number names the method or limit a result follows; it does not describe the product. Chapters below 1000 are procedures or limits; 1000-series chapters are informational. USP <905> is the compendial test for between-unit uniformity: it assays 10 units, so a 3-unit certificate cannot yield its acceptance value — the content row is a house check with <905> named as the reference only.

Tested by Vanguard Laboratory · Released September 18, 2026 · Verify: go.peptidology.co/biFnOS

Permanent URL: https://peptidology.co/coa/tesamorelin-size-11-99mg-batch-1777-lot-1777/

For research use only. Not intended for diagnostic or therapeutic use.

This certificate has been viewed 3 times.